← All trials
NCT01252420
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Nov 1, 2010
- Primary completion
- Nov 1, 2013
- Completion date
- Nov 1, 2014
- First posted
- —
- Last posted
- —
- Enrollment
- 330
- Arms / groups
- 1 / —
- Source
- AACT · pre-existing
Sponsors
- Monash UniversityLead sponsor
- University of OtagoCollaborator
- Southern Health, VictoriaCollaborator
- North Shore Hospital, New ZealandCollaborator
- Middlemore Hospital, New ZealandCollaborator
- University of AucklandCollaborator
- University of AdelaideCollaborator
- Eastern Health, CanadaCollaborator
- Monash UniversityOverall official - principal investigator
- University of New South WalesCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.